AGIO

Agios Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth↓ 0/10
  • Momentum↑ 5/10
Agios Pharmaceuticals sales and earnings growth
AGIO Growth
Low
  • Revenue Y/Y↑ 48.03%
  • EPS Y/Y↓ -160.03%
  • FCF Y/Y↓ 3.63%
Agios Pharmaceuticals gross and profit margin trends
AGIO Profitability
Neutral
  • Gross margin ↑ 88.30%
  • EPS margin↓ -764.00%
  • ROIC↓ -31.40%
Agios Pharmaceuticals net debt vs free cash flow
AGIO Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Agios Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗